COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,705 Articles (22,913 medRxiv, 8,792 bioRxiv)

Most recent first Previous |  Page 2341: Articles 23401-23410  | Next

Estimating Unreported Deaths Associated with COVID-19
Stear, B., Hernandez, K., Manian, V., Taylor, D., Conley, C.
10.1101/2020.08.29.20184176 — Posted: 2020-09-02
Could Deficiencies in South African Data Be the Explanation for Its Early SARS-CoV-2 Peak?
Childs, S. J.
10.1101/2020.08.31.20185108 — Posted: 2020-09-02
Modeling an epidemic in an imaginary small town
Bell, G.
10.1101/2020.08.31.20185256 — Posted: 2020-09-02
Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers
Figueiredo-Campos, P., Blankenhaus, B., Mota, C., Gomes, A., Serrano, M., Ariotti, S., Costa, C., Nunes-Cabaco, H., Mendes, A. M., Gaspar, P., Pereira-Santos, C. M., Rodrigues, F., Condeco, J., Escoval, A. M., Santos, M., Ramirez, M., Melo-Cristino, J., Simas, P. J., Vasconcelos, E., Afonso, A., Veldhoen, M.
10.1101/2020.08.30.20184309 — Posted: 2020-09-02
SARS-CoV-2 causes severe alveolar inflammation and barrier dysfunction
Deinhardt-Emmer, S., Böttcher, S., Häring, C., Giebeler, L., Henke, A., Zell, R., Hornung, F., Brandt, C., Marquet, M., Mosig, A. S., Pletz, M. W., Schacke, M., Roedel, J., Heller, R., Nietzsche, S., Löffler, B., Ehrhardt, C.
10.1101/2020.08.31.276725 — Posted: 2020-09-02
Cytotoxic lymphocytes are dysregulated in multisystem inflammatory syndrome in children
Beckmann, N. D., Comella, P. H., Cheng, E., Lepow, L., Beckmann, A. G., Mouskas, K., Simons, N. W., Hoffman, G. E., Francoeur, N. J., Del Valle, D. M., Kang, G., Moya, E., Wilkins, L., Le Berichel, J., Chang, C., Marvin, R., Calorossi, S., Lansky, A., Walker, L., Yi, N., Yu, A., Harnett, M., Eaton, M., Hatem, S., Jamal, H., Akyatan, A., Tabachnikova, A., Liharska, L. E., Cotter, L., Fennessey, B., Vaid, A., Barturen, G., Tyler, S. R., Shah, H., Wang, Y.-c., Hara Sridhar, S., Soto, J., Bose, S., Madrid, K., Ellis, E., Merzier, E., Vlachos, K., Fishman, N., Tin, M., Smith, M., Xie, H., Patel, M., Argueta, K., Harris, J., Karekar, N., Batchelor, C., Lacunza, J., Yishak, M., Tuballes, K., Scott, L., Kumar, A., Jaladanki, S., Thompson, R., Clark, E., Losic, B., The Mount Sinai COVID-19 Biobank Team, , Zhu, J., Wang, W., Kasarskis, A., Glicksberg, B. S., Nadkarni, G., Bogunovic, D., Elaiho, C., Gangadharan, S., Ofori-Amanfo, G., Alesso-Carra, K., Onel, K., Wilson, K. M., Argmann, C., Alarcon-Riquelme, M. E., Marron, T. U., Rahman, A., Kim-Schulze, S., Gnjatic, S., Gelb, B. D., Merad, M., Sebra, R., Schadt, E. E., Charney, A. W.
10.1101/2020.08.29.20182899 — Posted: 2020-09-02 Discussion: Offsite
Excess cardiovascular deaths in the beginning of COVID-19 outbreak
Wang, J., Zhu, J., Yang, H., Hu, Y., Sun, Y., Ying, Z., Qu, Y., Valdimarsdottir, U. A., Fang, F., Song, H.
10.1101/2020.08.29.20184317 — Posted: 2020-09-02
Impact of temperature on Covid 19 in India
Roy, M. P.
10.1101/2020.08.30.20184754 — Posted: 2020-09-02
Sample Pooling is a Viable Strategy for SARS-CoV-2 Detection in Low-Prevalence Settings
Chong, B. S., Tran, T., Druce, J., Ballard, S. A., Simpson, J. A., Catton, M.
10.1101/2020.08.26.20181719 — Posted: 2020-09-02
Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
Zuo, Y., Warnock, M., Harbaugh, A., Yalavarthi, S., Gockman, K., Zuo, M., Madison, J. A., Knight, J. S., Kanthi, Y., Lawrence, D. A.
10.1101/2020.08.29.20184358 — Posted: 2020-09-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).